• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Turk J Med Sci . Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study

tetano

Editor, Senior Moderator
Turk J Med Sci


. 2020 Nov 13.
doi: 10.3906/sag-2005-57. Online ahead of print.
Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study

Havva KocayİĞİt, Kezban ?zmen S?ner, Yakup Tomak, G?rkan Demİr, İbrahİm KocayİĞİt, Sel?uk Yaylaci, Yusuf Aydemİr, Mehmet K?roĞlu, OĞuz Karabay, Mehmet Halİl ?zt?rk, Alİ Fuat Erdem

Abstract

Background/aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Turkey on March 10, 2020 and the number of the patients are increasing day by day. Coronavirus disease 2019 (Covid-19) has high mortality rates in the intensive care unit (ICU). We aimed to describe the demographic characteristics, co-morbidities, treatment protocols and clinical outcomes among the critically ill patients admitted to ICU of our hospital.
Materials and methods: This cohort study included 103 consecutive patients who was laboratory confirmed Covid-19 and admitted to ICU of XXXXX Hospital between March 19 and April 13, 2020. The final date of the follow-up was April 18.
Results: The mean age of the patients was 69.6?14.1 years. Most of the patients had increased CRP (99%), serum ferritin (73.8%), D-dimer (82.5%) and hs-troponin levels (38.8%). 34 patients (33%) had lymphocytopenia, 24 patients (23.3%) had thrombocytopenia. 63 patients (61.2%) developed ARDS, 31 patients (30.1%) had acute kidney injury and 52 patients (50.5%) had MODS during follow-up. 62 patients (60.2%) received mechanical ventilation. As of April 18, of the 103 patients, 52 (50.5%) had died, 30 (29.1%) had been discharged from the ICU, 21 (20.4%) were still in the ICU.
Conclusions: Covid-19 has high mortality rates in ICU. Patients with elevated procalcitonin, hs-troponin, d-dimer and CRP levels and lower platelet count at admission has higher mortality.

Keywords: Covid-19; SARS-CoV-2; intensive care unit.
 
Back
Top Bottom